Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.

[1]  L. Bierut,et al.  Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  A. Irving,et al.  The GPR55 ligand L‐α‐lysophosphatidylinositol promotes RhoA‐dependent Ca2+ signaling and NFAT activation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. Yamashita,et al.  2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. , 2008, Journal of biochemistry.

[4]  R. Beninger,et al.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry , 2007, Neurotoxicity Research.

[5]  J. Hoenicka,et al.  Association in alcoholic patients between Psychopathic Traits and the additive effect of allelic forms of theCNR1 andFAAH endocannabinoid genes, and the 3′ Region of theDRD2 Gene , 2009, Neurotoxicity Research.

[6]  L. Stubbs,et al.  The gene encoding the central cannabinoid receptor is located in proximal mouse Chromosome 4 , 2009, Mammalian Genome.

[7]  A. Lu,et al.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  A. Brusco,et al.  Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus , 2008, Synapse.

[9]  N. Martin,et al.  Autosomal linkage analysis for cannabis use behaviors in Australian adults. , 2008, Drug and alcohol dependence.

[10]  T. Meitinger,et al.  Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa , 2008, Child and adolescent psychiatry and mental health.

[11]  J. Flitsch,et al.  Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. , 2008, Molecular genetics and metabolism.

[12]  Kent E Hutchison,et al.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. , 2008, Addiction.

[13]  Walter Heindel,et al.  Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression , 2008, European Neuropsychopharmacology.

[14]  G. Uhl,et al.  Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression , 2008, Annals of the New York Academy of Sciences.

[15]  A. Brusco,et al.  Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors , 2008, Annals of the New York Academy of Sciences.

[16]  E. Onaivi.  An Endocannabinoid Hypothesis of Drug Reward and Drug Addiction , 2008, Annals of the New York Academy of Sciences.

[17]  M. Hutz,et al.  Cannabinoid Type-1 Receptor Gene Polymorphisms Are Associated with Central Obesity in a Southern Brazilian Population , 2008, Disease markers.

[18]  Rafael J. Yáñez-Muñoz,et al.  A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner , 2008, Molecular and Cellular Neuroscience.

[19]  G. Wittert,et al.  Endocannabinoid system in food intake and metabolic regulation , 2008, Current opinion in lipidology.

[20]  I. Galve-Roperh,et al.  Mechanisms of control of neuron survival by the endocannabinoid system. , 2008, Current pharmaceutical design.

[21]  Vernell S. Williamson,et al.  Cannabinoid receptor 1 gene association with nicotine dependence. , 2008, Archives of general psychiatry.

[22]  Joseph P. Schacht,et al.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1. , 2008, Archives of general psychiatry.

[23]  Arpana Agrawal,et al.  Are there genetic influences on addiction: evidence from family, adoption and twin studies. , 2008, Addiction.

[24]  T. Hansen,et al.  Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. , 2008, Human molecular genetics.

[25]  M. Maccarrone,et al.  Interplay Between Endocannabinoids, Steroids and Cytokines in the Control of Human Reproduction , 2008, Journal of neuroendocrinology.

[26]  E. Hare,et al.  Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  D. Barrett,et al.  Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats , 2008, The European journal of neuroscience.

[28]  Pm Jenkinson,et al.  Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis , 2008, Multiple sclerosis.

[29]  George R. Uhl,et al.  Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects , 2008, PloS one.

[30]  K. Mackie,et al.  GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.

[31]  P. Gorwood,et al.  The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia , 2008, European Neuropsychopharmacology.

[32]  T. Kosten,et al.  Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates , 2008, The American journal of drug and alcohol abuse.

[33]  D. Lovinger.  Presynaptic modulation by endocannabinoids. , 2008, Handbook of experimental pharmacology.

[34]  S. Wiedmann,et al.  Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors. , 2008, International journal of molecular medicine.

[35]  S. Higuchi,et al.  Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans , 2007, The Pharmacogenomics Journal.

[36]  C. Ehlers,et al.  Association Between Single Nucleotide Polymorphisms in the Cannabinoid Receptor Gene (CNR1) and Impulsivity in Southwest California Indians , 2007, Twin Research and Human Genetics.

[37]  J. Fernández-Ruiz,et al.  Cannabinoids and neuroprotection in motor-related disorders. , 2007, CNS & neurological disorders drug targets.

[38]  G. Serra,et al.  Clinical Practice and Epidemiology in Mental Health a Possible Role for the Endocannabinoid System in the Neurobiology of Depression , 2007 .

[39]  A. Yamashita,et al.  Identification of GPR55 as a lysophosphatidylinositol receptor. , 2007, Biochemical and biophysical research communications.

[40]  R. Mechoulam,et al.  Endocannabinoids and Traumatic Brain Injury , 2007, Molecular Neurobiology.

[41]  J. Gelernter,et al.  CNR1 Variation Modulates Risk for Drug and Alcohol Dependence , 2007, Biological Psychiatry.

[42]  R. Puffenbarger,et al.  Genetic Polymorphisms of the Endocannabinoid System , 2007, Chemistry & biodiversity.

[43]  D. Piomelli,et al.  The anandamide transport inhibitor AM404 reduces ethanol self‐administration , 2007, The European journal of neuroscience.

[44]  S. Cherny,et al.  A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. , 2007, Drug and alcohol dependence.

[45]  W. Hul,et al.  The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men , 2007, Endocrine.

[46]  S. Werner,et al.  Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System , 2007, Science.

[47]  M. Notarnicola,et al.  Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population , 2007, International Journal of Obesity.

[48]  D. Tregouet,et al.  Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. , 2007, The Journal of clinical endocrinology and metabolism.

[49]  E. George,et al.  Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[50]  F. Ando,et al.  Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. , 2007, International journal of molecular medicine.

[51]  T. Meitinger,et al.  No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. , 2007, Molecular genetics and metabolism.

[52]  C. Ehlers,et al.  Age of first marijuana use and the occurrence of marijuana use disorders in Southwest California Indians , 2007, Pharmacology Biochemistry and Behavior.

[53]  V. Marzo,et al.  Cannabinoid receptors and their role in neuroprotection , 2007, NeuroMolecular Medicine.

[54]  E. Onaivi.  Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain , 2007, Neuropsychobiology.

[55]  T. Freund,et al.  Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia , 2006, Neuroscience.

[56]  S. Purcell,et al.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[57]  G. Gessa,et al.  Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404 , 2006, Neuropsychopharmacology.

[58]  A. Budney.  Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? , 2006, Addiction.

[59]  Saori Oka,et al.  Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. , 2006, Progress in lipid research.

[60]  G. Uhl,et al.  Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain , 2006, Annals of the New York Academy of Sciences.

[61]  J. Gelernter,et al.  Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[62]  J. Hoenicka,et al.  (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[63]  A. Agrawal,et al.  The genetic epidemiology of cannabis use, abuse and dependence. , 2006, Addiction.

[64]  J. Hewitt,et al.  Genetic and Environmental Vulnerabilities Underlying Adolescent Substance Use and Problem Use: General or Specific? , 2006, Behavior genetics.

[65]  E. Bullmore,et al.  Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces , 2006, The European journal of neuroscience.

[66]  Paul F. Smith,et al.  Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study , 2006, Neuroscience Letters.

[67]  F. Petitet,et al.  GPR55 as a New Cannabinoid Receptor: Still a Long Way to Prove It , 2006, Chemical biology & drug design.

[68]  R. Bertorelli,et al.  CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms , 2006, The European journal of neuroscience.

[69]  M. Krebs,et al.  (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population , 2006, The Pharmacogenomics Journal.

[70]  G. Uhl,et al.  Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain , 2006, Brain Research.

[71]  H. Andersson,et al.  Amino-Terminal Processing of the Human Cannabinoid Receptor 1 , 2006, Journal of receptor and signal transduction research.

[72]  Jan Freudenberg,et al.  Cannabinoid receptor type 2 gene is associated with human osteoporosis. , 2005, Human molecular genetics.

[73]  G. Uhl,et al.  Endocannabinoid Receptor Genetics and Marijuana Use , 2005 .

[74]  K. Mackie,et al.  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .

[75]  D. Deutsch,et al.  Anandamide transport: a critical review. , 2005, Life sciences.

[76]  A. Gerber,et al.  Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders , 2005, Journal of leukocyte biology.

[77]  J. Salamone,et al.  Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. , 2005, Current opinion in pharmacology.

[78]  P. Beaulieu.  Toxic effects of cannabis and cannabinoids: Animal data. , 2005, Pain research & management.

[79]  J. Hoenicka,et al.  Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) , 2005, The Pharmacogenomics Journal.

[80]  G. Uhl,et al.  Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse , 2004, Molecular Psychiatry.

[81]  A. Barbáchano,et al.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.

[82]  J. Romero,et al.  Role of the endocannabinoid system in Alzheimer's disease: new perspectives. , 2004, Life sciences.

[83]  M. Nöthen,et al.  Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[84]  N. Stella,et al.  Cannabinoids and neuroinflammation , 2004, British journal of pharmacology.

[85]  K. Kanyas,et al.  Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[86]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[87]  V. Arango,et al.  Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims , 2004, Molecular Psychiatry.

[88]  F. Grotenhermen.  Pharmacology of cannabinoids. , 2004, Neuro endocrinology letters.

[89]  Terry J. Smith,et al.  Cannabinoids and the human uterus during pregnancy. , 2004, American journal of obstetrics and gynecology.

[90]  Alberto Rábano,et al.  Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains , 2003, The Journal of Neuroscience.

[91]  B. Bondy,et al.  Alcoholism-related phenotypes and genetic variants of the CB1 receptor , 2003, European Archives of Psychiatry and Clinical Neuroscience.

[92]  M. Mitchell,et al.  Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. , 2003, Placenta.

[93]  G. von Heijne,et al.  Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. , 2003, Molecular pharmacology.

[94]  J. Hewitt,et al.  Family transmission of marijuana use, abuse, and dependence. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[95]  J. Hoenicka,et al.  Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients , 2003, Molecular Psychiatry.

[96]  Y. Hurd,et al.  Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain , 2003, Neuroscience.

[97]  Alexander J Stokes,et al.  Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells1 , 2003, The Journal of Immunology.

[98]  Á. Pazos,et al.  Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain , 2003, The European journal of neuroscience.

[99]  M. Mitchell,et al.  Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. , 2003, Placenta.

[100]  J. Manzanares,et al.  Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice , 2003, Journal of neurochemistry.

[101]  D. Deutsch,et al.  Evidence against the presence of an anandamide transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[102]  D. Cota,et al.  Endogenous cannabinoid system as a modulator of food intake , 2003, International Journal of Obesity.

[103]  R. Tyndale,et al.  Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.

[104]  Neil Smith.  A review of the published literature into cannabis withdrawal symptoms in human users. , 2002, Addiction.

[105]  G. Uhl,et al.  Cannabinoid receptor genetics and behavior , 2002 .

[106]  G. Uhl,et al.  Endocannabinoids and cannabinoid receptor genetics , 2002, Progress in Neurobiology.

[107]  J. Samochowiec,et al.  Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. , 2002, Drug and alcohol dependence.

[108]  J. Crabbe.  Genetic contributions to addiction. , 2002, Annual review of psychology.

[109]  H Ujike,et al.  CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.

[110]  N. Griffon,et al.  Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. , 2001, American journal of medical genetics.

[111]  J. Gelernter,et al.  Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence , 2001, Molecular Psychiatry.

[112]  S. Tsai,et al.  Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders. , 2001, American journal of medical genetics.

[113]  D. Heller,et al.  The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users , 2001, Addiction biology.

[114]  P. Buckland.  Genetic association studies of alcoholism--problems with the candidate gene approach. , 2001, Alcohol and alcoholism.

[115]  S. O’Brien,et al.  Molecular phylogenetics and the origins of placental mammals , 2001, Nature.

[116]  S. Tsai,et al.  Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. , 2000, Psychiatric genetics.

[117]  K. Bucholz,et al.  Transitions in drinking in adolescent females: evidence from the Missouri adolescent female twin study. , 2000, Alcoholism, clinical and experimental research.

[118]  S. Narula,et al.  Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. , 2000, Molecular pharmacology.

[119]  D. Collier,et al.  No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population , 2000, Molecular Psychiatry.

[120]  Alison M. Goate,et al.  The Candidate Gene Approach , 2000, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[121]  F. Weiss,et al.  The dopamine hypothesis of reward: past and current status , 1999, Trends in Neurosciences.

[122]  D. Lewis,et al.  The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors , 1999, The Journal of Neuroscience.

[123]  N. Andreasen,et al.  Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. , 1999, American journal of medical genetics.

[124]  K. Müller-Vahl,et al.  A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. , 1999, Molecular and cellular probes.

[125]  M. Parker,et al.  Expression of cannabinoid receptors and their gene transcripts in human blood cells , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[126]  K. Waku,et al.  Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor , 1999, The Journal of Biological Chemistry.

[127]  U. Francke,et al.  Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation. , 1998, Genomics.

[128]  Jih-Heng Li,et al.  Genetic toxicology of abused drugs: a brief review. , 1998, Mutagenesis.

[129]  J. Lowe,et al.  CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. , 1998, The Journal of pharmacology and experimental therapeutics.

[130]  D. Gurwitz,et al.  Do endogenous cannabinoids contribute to HIV-mediated immune failure? , 1998, Molecular medicine today.

[131]  C. Gerhardt,et al.  Functional characteristics of heterologously expressed 5-HT receptors. , 1997, European journal of pharmacology.

[132]  E. Gershon,et al.  Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. , 1997, Genomics.

[133]  D. Comings,et al.  Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.

[134]  D. Comings,et al.  Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential , 1997, Molecular Psychiatry.

[135]  N. Kaminski,et al.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. , 1997, Toxicology and applied pharmacology.

[136]  L. Matsuda,et al.  Molecular aspects of cannabinoid receptors. , 1997, Critical reviews in neurobiology.

[137]  J. Lowe,et al.  Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. , 1996, The Journal of pharmacology and experimental therapeutics.

[138]  P. Casellas,et al.  Characterization of two cloned human CB1 cannabinoid receptor isoforms. , 1996, The Journal of pharmacology and experimental therapeutics.

[139]  G. Chaudhuri,et al.  Cannabinoid receptor genes , 1996, Progress in Neurobiology.

[140]  Comings De.  Genetic factors in drug abuse and dependence. , 1996 .

[141]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[142]  G. Chaudhuri,et al.  Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. , 1995, DNA sequence : the journal of DNA sequencing and mapping.

[143]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[144]  G Vassart,et al.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis. , 1991, The Biochemical journal.

[145]  T. Bonner,et al.  HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR). , 1991, Nucleic acids research.

[146]  T. Bonner,et al.  Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. , 1991, The New biologist.

[147]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[148]  H. Jarrell,et al.  The orientation of (-)-delta 9-tetrahydrocannabinol in DPPC bilayers as determined from solid-state 2H-NMR. , 1989, Biochimica et biophysica acta.

[149]  R. Harris,et al.  Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. , 1985, The Journal of pharmacology and experimental therapeutics.